Related Experiment Videos

Cumulative increase in serum furosemide concentration following repeated doses in the newborn

Insights

Repeat doses of furosemide (a diuretic) lead to higher drug levels in newborn plasma. This indicates potential accumulation, possibly due to reduced drug clearance in infants.

Area of Science:

  • Neonatal pharmacology
  • Clinical pharmacy
  • Pediatric drug monitoring

Background:

  • Furosemide is a common diuretic used in neonates.
  • Understanding drug accumulation is crucial for safe and effective neonatal care.

Purpose of the Study:

  • To investigate plasma accumulation of furosemide with repeated dosing in newborns.
  • To assess the impact of repeated furosemide administration on drug concentrations.

Main Methods:

  • Eight newborns received 1-mg/kg intravenous furosemide every 12 hours for four doses.
  • Serum furosemide peak and trough concentrations were measured using High-Performance Liquid Chromatography (HPLC).

Main Results:

  • Mean peak serum furosemide levels significantly increased with repeated doses (p < .05).
  • Mean trough concentrations plateaued, suggesting a steady state was reached.
  • Increased drug levels indicate potential plasma accumulation.

Conclusions:

  • Repeat dosing of furosemide in newborns can lead to plasma accumulation.
  • This accumulation is likely due to decreased plasma clearance or altered volume of distribution.
  • Findings highlight the importance of monitoring furosemide levels in neonatal populations.

Related Concept Videos